Inventor
NOMURA SUMIHIRO
JP29 patents
⚠️ This page may combine multiple inventors who share the name “NOMURA SUMIHIRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TANABE SEIYAKU CO
14 patentsUS7026501B2Apr 11, 2006
Inhibitors of α4 mediated cell adhesion
TANABE SEIYAKU CO26 citations91
US6114529ASep 5, 2000
S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
TANABE SEIYAKU CO13 citations82
US5332754AJul 26, 1994
Naphthyloxazolidone derivatives
TANABE SEIYAKU CO16 citations82
US6015901AJan 18, 2000
S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
TANABE SEIYAKU CO7 citations74
US4839360AJun 13, 1989
Lactam derivatives
TANABE SEIYAKU CO9 citations74
US5409936AApr 25, 1995
Imidazopyridine derivatives for the treatment of hypertension
TANABE SEIYAKU CO4 citations72
US6388078B1May 14, 2002
S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
TANABE SEIYAKU CO1 citations63
US5932732AAug 3, 1999
S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
TANABE SEIYAKU CO1 citations63
US5510354AApr 23, 1996
Imidazopyridine derivatives
TANABE SEIYAKU CO2 citations61
US5424316AJun 13, 1995
Imidazopyridine derivatives for the treatment of hypertension
TANABE SEIYAKU CO3 citations61
US5268377ADec 7, 1993
Imidazoindolizine derivatives process for preparation thereof and use thereof to treat hypertension
TANABE SEIYAKU CO2 citations61
US7060832B2Jun 13, 2006
Nitrogen-containing fused heterocyclic carboxylic acids having an absolute configuration of “R”
TANABE SEIYAKU CO0 citations52
US6716983B2Apr 6, 2004
S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
TANABE SEIYAKU CO0 citations52
US6277992B1Aug 21, 2001
S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
TANABE SEIYAKU CO0 citations52
MITSUBISHI TANABE PHARMA CORP
8 patentsUS7943582B2May 17, 2011
Crystalline form of 1-(β-D-glucopyransoyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzene hemihydrate
MITSUBISHI TANABE PHARMA CORP31 citations92
US7943788B2May 17, 2011
Glucopyranoside compound
MITSUBISHI TANABE PHARMA CORP36 citations91
US7851617B2Dec 14, 2010
Indole derivatives
MITSUBISHI TANABE PHARMA CORP6 citations68
US7935674B2May 3, 2011
Indole derivatives
MITSUBISHI TANABE PHARMA CORP3 citations63
US7521430B2Apr 21, 2009
N-glucoside compounds having an inhibitory activity against sodium-dependent glucose transporter
MITSUBISHI TANABE PHARMA CORP1 citations51
US7872151B2Jan 18, 2011
Inhibitors of α4 mediated cell adhesion
MITSUBISHI TANABE PHARMA CORP0 citations50
US7671090B2Mar 2, 2010
Inhibitors of α4 mediated cell adhesion
MITSUBISHI TANABE PHARMA CORP0 citations50
US7456217B2Nov 25, 2008
Inhibitors of alpha4 mediated cell adhesion
MITSUBISHI TANABE PHARMA CORP0 citations50
NOMURA SUMIHIRO
4 patentsUS8513202B2Aug 20, 2013
Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate
NOMURA SUMIHIRO9 citations82
US8222219B2Jul 17, 2012
Glucopyranoside compound
NOMURA SUMIHIRO11 citations81
US8785403B2Jul 22, 2014
Glucopyranoside compound
NOMURA SUMIHIRO3 citations60
US8202984B2Jun 19, 2012
Glucopyranoside compound
NOMURA SUMIHIRO4 citations60